Optogenetics is the latest new subdiscipline in brain sciences that merges optical imaging, protein engineering and genetic dissection of neuronal circuits to optically monitor and control brain activity with high spatial and temporal precision. In this review, the conceptual framework that fueled the development of this methodology is fi rst introduced and the central tools utilized in monitoring and controlling of neuronal circuit elements using light are described. How this innovative approach fosters our understanding of both physiological and pathophysiological properties of brain networks is then discussed. Finally, the potential clinical application of optogenetic approaches is outlined.
Introduction
Advances in brain science are often driven by methodological progress in other disciplines. Two prominent fi elds traditionally leading the progression of neuroscience are optics and genetics. The former, optical methods, has been essential for neuroscientists since the seminal microscopic examinations of nerve cells by Santiago Ram ó n y Cajal and continues to drive progress with modern super-resolution and two-photon microscopy ( 1, 2 ) . Genetic methods to manipulate brain circuitry at the molecular, cellular and circuit level have a shorter history but similarly have a vast impact on neurosciences ( 3, 4 ) . Recently, the combination of optics and genetics has led to the innovative fi eld of optogenetics ( 5 -8 ) .
Optogenetics address two main obstacles that brain scientists must overcome. The fi rst diffi culty arises from the fact that neuronal circuits generate and process signals through microscopically small and numerous parallel channels at the millisecond timescale. Optical methods provide a measurement technology for an accurate detection of these signals with the required spatial and temporal resolution. The second obstacle is to overcome neuronal diversity. The brain features a complex composition of varied cell types, each of which has different intrinsic properties and modes of intercellular interaction. Because of this diversity, the function of neuronal circuits cannot be deduced from the attributes of single cells. Identifi cation, monitoring and control of defi ned cell types can be achieved by genetically targeting fl uorescent reporter molecules. Since this approach allows to address large cell populations with high specifi city, it opens new ways to investigate brain functions at the level of whole circuitries without neglecting cell type specifi city.
In this review, the main features of genetically encoded tools for monitoring and controlling neuronal activity are fi rst described. In the second part, how these tools help elucidate the function of brain circuits is highlighted and their potential in future clinical applications is also addressed.
Imaging brain function using optogenetic probes
The 18th century scientist Luigi Galvani (1737 -1798) proposed that electricity powers movement in animals. His seminal work initiated the scientifi c discipline of electrophysiology, which today, perhaps more than ever, strives to address the classical question of how our brain ' does what it does ' . After many decades of methodological refi nement, electrophysiology has become the standard to investigate neuronal signals at the level of single cells, dissected networks and intact brains. The most traditional tools of an electrophysiologist are electrodes of various types that are placed on the scalp to record an electroencephalogram (EEG) or inserted into single nerve cells. Electrodes and electronic equipment can follow the neuronal signals that occur at a timescale of milliseconds with ease and excellent recording quality. However, classical electrophysiology struggles with a strict limitation. Although signals of individual cells can be readily recorded, it is unpractical to parallelize this technique to obtain recordings from more than a few tens of cells simultaneously. Because brain function is based on the synchronized operation of many neurons, their inter related processes cannot be deduced from signals of a few selected cells. Given the vast numbers of nerve cells (100,000,000,000 in the human brain), this is a serious limitation. Even in cases such as the EEG, where recordings are obtained from large populations of cells, spatial resolution suffers and does not reveal much detail about the specifi c circuit elements involved in signal generation.
As an alternative to microelectrodes, the use of optical reporters allows for concurrent detection of cell activity across populations of inter connected neurons. Traditional optical imaging techniques are mainly based on the use of chemical dyes including voltage-sensitive, calcium-sensitive or pH-sensitive indicators that convert neuronal activity into optical signals. Although optical imaging using indicator dyes such as the cell-permeant acetoxymethyl (AM) ester dyes, solves the problem of simultaneously monitoring a large number of cells, these dyes typically stain cells unselectively. Genetically encoded indicators offer an enticing alternative because they can target specifi c neuronal populations while maintaining the ability to record a large number of neurons at the same time to observe how specifi c populations of cells are inter-connected.
How can proteins be genetically engineered to optically report neuronal activity ? The success of protein engineering lies in its ability to combine components of naturally evolved proteins with specifi c functions to generate a redesigned protein with a novel function. This artifi cial protein can then be functionally enhanced and fi ne-tuned by mutagenesis. To genetically engineer an optogenetic indicator that can faithfully impart brain activity, a protein component that senses neuronal modulations such as membrane voltage or calcium concentration changes is fused with fl uorescent proteins (FP) from marine animals such as jelly fi shes and corals ( Figure  1 A) . Functionally, the sensing proteins undergo structural changes, which successively alter the intensity of the FP. To observe the FP component ' s response to the conformational changes of the sensing protein, several strategies have been effectively designed. In the simplest case, the photo-physical properties of a single FP are directly modulated by structural changes imposed by the sensor. Another coupling strategy is based on the F ö rster resonance energy transfer (FRET) between two FP color variants ( Figure 1B ). In this case, conformational movement imposed by the sensing protein causes a change in the distance or the orientation of two FPs, which in turn affects the ratio of the fl uorescence emission in the two emission bands (Figure 2 ).
The two general types of sensing proteins engineered to the FPs are the voltage-sensitive membrane proteins and the calcium-binding proteins. As the activity of a neuron is based on the changes in voltage across its cell membrane, genetically encoded optical reporters with membrane-voltage sensitivity are the natural choice and over the last 15 years, these reporter proteins have progressed considerably ( 7, 9, 10 ) . Initial design concepts were based on the exploitation of voltage-dependent conformational changes associated with voltage-gated ion channels or their isolated voltage sensor domain using either a single FP approach or a FRET pair of FPs ( 11, 12 ) to achieve an optical report of changes in membrane potential. More recently, largely improved second generation voltage-sensitive fl uorescent proteins (VSFP2s) were developed by replacing the sensor protein with the voltage-sensing domain of the non-ion channel protein Ciona intestinalis voltage sensor-containing phosphatase (Ci-VSP), leading to sensors with increased targeting to the plasma membrane and reliable responsiveness to membrane potential signaling in isolated cells ( Figure 1C ) from brain slices and living mice (Figure 3 ). These optogenetic voltage indicators brain tissues has yet to be demonstrated and might be limited by their low brightness (about 1000-fold lower fl uorescence quantum yield as compared to FP-based sensors).
Optical calcium probes, an alternative to voltage indicators, utilize calcium-binding proteins and are currently widely applied to monitor action potentials in neuronal circuits. Action potential fi ring of neurons is associated with activation of voltage-dependent calcium channels, which causes a large rise in intracellular calcium concentration. In this case, calcium sensors are ideal as action potentialassociated calcium changes and can be optically imaged with a larger signal-to-noise ratio as compared to imaging changes in voltage signals. Because the original proof of principle has been demonstrated by two independent groups ( 17, 18 ), an ever-growing variety of fl uorescent genetically encoded calcium indicators have been developed. These are made by combining calcium-binding proteins such as calmodulin with its interacting peptide M13 or troponin-C with fl uorescent proteins. Binding of calcium triggers a structural rearrangement of the sensor protein that modulates the fl uorescent output using either a single circularly permuted FP ( 19 -22 ) or a FRET pair of FPs ( 18, 22 ) . Transgenic mice that express the genetically encoded calcium indicator GCaMP2 were one of the fi rst examples where researchers could take advantage of this emerging technology to monitor neuronal activates ( Figure 4 ) ( 23 -25 ).
Controlling brain function using optogenetic actuators
Traditional electrophysiological techniques not only include the use of recording electrodes but also stimulation electrodes to activate signaling mechanisms that regulate neuronal circuits. As discussed for recording of electrical activity, manipulating neuronal activity with electrodes often lacks specifi city because all neurons and even by-passing axons are stimulated with extracellular electrodes. Although a single cell can effi ciently and selectively be stimulated by an intracellular electrode, there is no practical electrode-based method to stimulate a specifi ed group of neurons as they are intermingled with other neurons and their processes. Engineered proteins that transform light signals into neuronal excitation or inhibition provide an elegant and powerful approach to control a large number of cells of the same type and putative common function, while leaving the others unaffected. Consistent with the core concept of optogenetics, light can be delivered and controlled conveniently by optical methods with high temporal and spatial precision for manipulation of neuronal functions, whereas the engineered proteins can be placed into defi ned cell types using genetic methods. These optogenetic actuator proteins have been used for the control of neuronal circuits in living animals at the millisecond timescale.
Optical methods of control that employ genetically encoded protein components had been envisaged and developed more than 10 years ago and include ion channels that were made light sensitive by chemical treatment (26) . These rely on a photosensitive molecule (a photo switch) or a specifi c ligand (ATP enabled the monitoring of neuronal circuit activities in living mice ( 13 ) . Initial VSFP variants exhibited kinetic properties with time constants between a few and tens of milliseconds and therefore are more suitable to report synaptic potentials than fast action potentials ( 13, 14 ) . More recent versions of VSFPs enable the optical recording of action potentials from individual neurons in single sweeps (15, Mishina et al. unpublished results). Recently, rhodopsin-based voltage probes have been described ( 16 ) . However, the ability of these emerging class of voltage reporters to record voltage signals in intact that is contained by a photolabile protecting group, in the case of P2X 2 ) to switch on and activate the proteins for neuronal control. More recently, single component optical systems entailing ion channels and ion pumps that respond directly to light and genetically introduced to target cells have become the leading tool in optogenetics. Their principle function evolved naturally from bacterial opsins such as bacteriolrhodopsin and halorhodopsin; ion pumps discovered in the 1970s that are activated by green and yellow light, respectively ( 27 ) . Although these proteins have been known and investigated for quite some time, it was the description of channelrhodopsin-2 (ChR2) in 2003 ( 28 ) that triggered a rapid advancement of optogenetic applications in neurosciences. ChR2 was the fi rst microbial opsin based optogenetic actuator protein that allowed the use of light for the activation of mammalian neurons with millisecond-scale temporal precision ( Figure 5 ) ( 29, 30 cationic current to depolarize the membrane and trigger action potential fi ring ( Figure 5 ). New classes of channelrhodopsin variants, both found in natural resources and engineered, improved and expanded the application of this method to optically activate neurons. Although ChR2 allows for the excitation of neuronal activity, several inhibitory optogenetic manipulations have also been developed. They include a light driven chloride pump from Natronomonas pharaonis (NpHR or ' halorhodopsin ' ) and a proton pump from Halorubrum sodomense (archaerhodopsin-3 or ' Arch ' ) (31) (32) (33) . Because these microbial proteins produce a hyper polarizing membrane current when activated by light, they can be used to prevent action potential generation ( Figure 5 ). As NpHR is activated by light of longer wavelength than ChR2, this difference in activation spectra can be used for bidirectional control for both stimulation and inhibition of genetically targeted neurons that express both ChR2 and NpHR with temporal precision and without spectral interference (34) .
Optogenetic electrophysiology
In the preceding two paragraphs, we have described the optogenic probes for monitoring and controlling neuronal activity separately. As classical electrophysiology relies on the combination of electrical recordings and electrical stimulation, a complete optogenetic approach to electrophysiology requires the combined application of both optical reporters of membrane voltage and light activated ion channels/pumps within the same experiment. To date, only the combination of indirect voltage measurements with genetically encoded calcium sensors and opsin-based stimulation has been demonstrated ( 35 ) , whereas a true all-optogenic electrophysiology requires additional developmental efforts. The main diffi culty of this approach is to establish appropriate reporter-actuator pairs with non-overlapping excitation/activation spectra. The activation spectrum of all long-wavelength opsin-based control tools have a signifi cant tail at shorter wavelengths and so their combination with reporters that are excited by blue light is hampered by signifi cant cross activation. Currently, the most promising strategy is to control with blue light and monitor at far red wavelengths. Possible candidates for this approach are ChR variants and red shifted VSFPs or the emerging opsin based voltage-indicating proteins ( 16 ) . Combining monitoring and control will allow researchers to establish correlation and causation at the level of defi ned cell populations within one experiment.
Allocation of optogenetic proteins to specifi c cell types
Protein-based reporters and actuators of neuronal activity can be directed to specifi ed cell types using genetic methods. This raises the question of how cell types are defi ned and how genetic targeting is achieved in practice. There is no doubt that neuronal circuits are composed of neurons that exhibit different properties and morphologies and use various synaptic and non-synaptic pathways to infl uence one another. Classifi cation of neurons into cell types depends on the unequivocal identifi cation of those features that distinguish one type of neuron from another. An advanced example of such typology is the Petilla Interneuron Nomenclature ( 36 ) . Many of the parameters that differentiate best between cell types in such classifi cation schemes are defi ned by the gene products expressed in these cells. Therefore, genetic messages and gene products are useful markers for phenotypebased cell type classifi cation schemes. In turn, different cell types can be specifi cally labeled with optogenetic reporter and actuator proteins by using the regulatory sequences (promoters) of these marker genes. In addition to canonical genotype-based cell type classifi cation schemes, genetic methods also allow the defi nition of cell populations via their activities by using activity-dependent regulatory sequences that correlate with specifi c circuit functions to which these neurons contribute. Delivery of these assemblies of regulatory and protein-encoding DNA neurons in living animals can be achieved via transgenic approaches, viral approaches or a combination of both. Thus, the expression of fl uorescent proteins in genetically specifi ed populations of neuronal cells has been achieved using several regulatory gene sequences such as promoters for glutamic acid decarboxylase ( 37 ), odorant receptors ( 38 ) and K + channel Kv3.1 ( 39 ) to name a few. For instance, the regulatory sequences of Kv3.1 were used to generate transgenic mice expressing the fl uorescent protein calcium sensor GCaMP2 (Figure 4) ( 23, 24 ) .
Virus particles carrying cell-type specifi c promoters in addition to sequences for optogenetic tools have also been explored but most, if not all, promoters tested to date for this purpose are either not specifi c enough or too weak to drive suffi cient expression levels of the gene product. In most recent studies that employ optogenetic stimulation techniques, viruses have been used to target the expression of optogenetic tools to multiple cell types using a strong promoter in a loxP/ Cre recombinase-dependent system under a FLEX confi guration ( 40 ) . In this approach, Cre recombinase is used to invert a reverse coding sequence with fl anking anti-parallel loxP-type recombination sites. The inversion of the sequence then turns on the transcription of the gene of interest. The advantage of this approach is that expression of Cre recombinase can be driven by a weak but highly cell-type specifi c promoter and a strong but ubiquitous promoter ensures suffi ciently high expression levels of the recombinant protein. However, viral gene delivery has several limitations including low transgene capacity and spatially inhomogeneous transduction effi cacy, typically concentrated around the injection site. This limitation can be overcome by the generation of mice that carry the coding sequence of the optogenetic tool under a strong promoter in a Cre-dependent confi guration. Such transgenic mice can be crossed with available Cre-driver mouse lines to target the expression of the transgene to specifi c cells or tissues without limitations in the size of the gene or the area of expression.
Unfortunately, only a few cell types are defi ned by the expression of a single gene. However, single gene products can defi ne large classes of cells (e.g., inhibitory cells vs. excitatory cells). Differential labeling of similar cells could be achieved using combinatorial strategies that require the expression of two or more marker gene products or by taking advantage of anatomical features. Anatomical constraints such as long-range projections in conjunction with combinatorial strategies have been elegantly pioneered by Ed Callaway and collaborators ( 3 ) .
Marker genes defi ne cell populations that might be subdivided on the basis of functional criteria such as their recruitment under distinct tasks. Therefore, future work should aim at the development of genetic approaches for targeting groups of neurons according to their spatio-temporal activity patterns rather than their genetic identity. Such advancement would allow the imaging of co-active neurons or neuronal assemblies that carry information to guide behavior in complex mammalian circuits. This could be achieved by using activity-dependant regulatory sequences such as immediate early genes Arc, Egr1 and Fos ( 41, 42 ) .
Recent advances enabled by optogenetic methods in understanding neuronal mechanisms and diseases
Optogenetics is a revolutionary new fi eld but at the same time it evolved over decades from a visionary conceptual framework and its parent disciplines. Optogenetics is more than ' just a toolbox ' or ' just a method ' . It has been motivated by the insight on how to experimentally bridge the complexity and diversity of molecular and cellular neurophysiology with behavioral functions observed in living animals. This bridge between the structural and functional levels is a necessary step for both reverse and forward engineering of the human brain, one of the most ambitious scientifi c goals of modern biomedical sciences.
Optogenetic methodologies have already enabled novel experimental approaches in a variety of neuroscience fi elds. Optogenetic actuators enabled four types of experimental questions and issues to be addressed: (i) Is the activation of specifi c cells type or a circuit suffi cient and necessary to trigger a behavior ? (ii) Are specifi c circuitry properties driven by a specifi c cell type ? (iii) What are the cellular substrates of certain learned behaviors ? Finally, (iv) experiments aimed at exploring ways to ' fi x ' circuit malfunctions i.e., how can certain cells be perturbed, either inhibited or stimulated, to repair adverse circuit functions ?
Question (i) of whether the activity of certain cell groups is suffi cient and necessary to generate a specifi c behavioral outcome has been successfully addressed. Using optogenetic tools for control demonstrated that phasic fi ring of dopaminergic neurons can induce behavioral conditioning, the functional identifi cation of an aggression locus in the mouse hypothalamus ( 43 -45 ) . ChR2 derivatives have been used to address the circuit mechanistic question (ii), for instance, by elucidating the involvement of parvalbumin expressing fast spiking cortical interneurons in the generation of gamma oscillations and their relation to sensory responses ( 46, 47 ) . Optogenetic excitation has also been used to defi ne the cellular substrates of anxiety as a learned behavior from question (iii) ( 48, 49 ) . A more complex function of neuronal circuits is the consolidation of memory, a process that stabilizes a memory trace after initial acquisition. A recent study used optogenetic control techniques to elucidate the consequences of interrupted sleep on memory consolidation ( 50 ) . Finally, circuit malfunctions that might be ' fi xed ' by optogenetic intervention (iv) have been explored by optogenetic control of epileptiform activity and reactivation of dopaminergic mechanism in animal models of Parkinson ' s disease ( 51 -54 ) .
Potential clinical applications of optogenetics
Optogenetics has not only been successfully used to understand normal and disturbed brain circuits in animal models but there are already several early stage projects that aim at moving this technology towards therapeutic applications in human patients. There are two principal clinically relevant strategies that are empowered by optogenetics, namely brain stimulation and prosthetic devices.
The stimulation strategies are inspired by deep brain stimulation (DBS) technologies that use electrode-based electrical brain stimulation in the treatment of neurological disorders. The most prominent clinical application of DBS is the treatment of Parkinson ' s disease but many other disease states that arise from disturbed dynamics of neuronal circuits might also become a target for optogenetic stimulation techniques. Relevant disease states include depression, obsessivecompulsive personality disorder, sleep disorders, addiction, tremors, dystonia, dyskinesia, pain, epilepsia and Gilles de la Tourrette syndrome. Neuropsychiatric diseases are another potential target for optogenetic stimulation techniques. For instance, it has been proposed that specifi c perturbation of cortical circuit dynamics might be of therapeutic benefi t for patients with schizophrenia. Because both the target cells and the actual pathway and neuronal mechanism of these many brain diseases are only partially clarifi ed, optogenetics has the potential to explore specifi c strategies for their treatment.
The idea of employing optogenetics for prosthetic devices has been spearheaded by research on blindness due to defects in the natural light sensors, the photoreceptor cells in the retina. Indeed, hundred of thousands of patients worldwide suffer from blindness due to retinitis pigmentosa, a disease that gradually destroys the photoreceptors in the retina. To recover sight in those patients, electronic devices have been developed with some success. In recent years, optogenetics has been explored as an alternative as a less invasive technology to restore sight in retinitis pigmentosa patients. The approach involves the expression of engineered light-activated cation channels in the ganglion cells that normally receive input from photoreceptors ( 55 -57 ) .
Moreover, there are emerging ideas to employ optogenetic methods to machine brain interfaces to assist in the control of prostheses to substitute lost bodily functions. The potential clinical application includes the rehabilitation of hemiplegic patients. Current efforts to control their muscle functions are based on traditional electrophysiological methods. In the future, such interfaces might take advantage of optogenetic tools for both monitoring and control of neurons and perhaps even muscles ( 58 ) . Whether optogenetics will make its way into clinical routine will depend on many factors including the safety of gene delivery methods. First reports on the use of optogenetics in primates showed that ChR2 can be safely expressed in macaque prefrontal cortex and can mediate optical neuromodulation over many months without immunological problems ( 59 ) .
Expert opinion
Optogenetics is based on the powerful conglomeration of two established methods and developed from a specifi c conceptual framework that emphasizes the role of genetically defi ned populations of neurons rather than individual cells or brain regions. It has not only enabled new experimental approaches to address cellular and system biological questions but has also helped to close the gap between our understandings of these distant levels of brain organization. The potential to reverse engineer neuronal circuitries will be an essential step towards a comprehensive understanding of the human brain. We expect that the use of optogenetic approaches will continue to evolve and spread into physiology laboratories for further development and application. In the near future, experimental information obtained with optogenetic methods will be combined with large-scale computational simulation of neuronal circuits to enable a profound understanding of normal brain function and hopefully therapeutic approaches to reverse adverse brain conditions.
